News
The FDA published their complete response letters to drug and biological product applications as part of an effort for more transparency.
The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...
The FDA determined the data from STARGLO did not provide sufficient evidence to support approving glofitamab-gxbm (Columvi) in combination with gemcitabine and oxaliplatin to treat relapsed/refractory ...
The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL patients who are not eligible for autologous stem cell transplant, Roche ...
12hOpinion
The New Republic on MSNTrump and JD Vance Humiliatingly Flub Response to WSJ Epstein StoryThe Wall Street Journal published a birthday note Donald Trump once wrote to Jeffrey Epstein, describing the financier as a ...
Elon Musk has weighed back into the Donald Trump and Jeffrey Epstein drama he helped create with a string of spicy social ...
The 2003 gift was a bound book of birthday letters. According to the Journal, Trump’s was remarkably lurid—“several lines of ...
There’s no “magic formula,” an attorney and former Labor Department official told HR Dive, but there are some best practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results